IP Library Granted Patent US 10,577,359
Granted Patent B2
US 10,577,359 · App. 15/425,198 · Granted Mar 3, 2020

Preparation of 2′-fluoro-2′-alkyl-substituted or other optionally substituted ribofuranosyl pyrimidines and purines and their derivatives

Inventors: Byoung-Kwon Chun (Pleasanton, CA); Jinfa Du (Redwood City, CA); Suguna Rachakonda (Copley, OH); Peiyuan Wang (San Mateo, CA)
Assignee: Gilead Pharmasset LLC
C07D411/04A61K31/7072C07D307/20C07D307/33C07D317/00C07D317/30C07D405/04C07D407/04C07H15/203C07H19/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,577,359
App. No.
15/425,198
Granted
Mar 3, 2020
Kind
B2
Abstract

The present invention provides (i) processes for preparing a 2′-deoxy-2′-fluoro-2′-methyl-D-ribonolactone derivatives, (ii) conversion of intermediate lactones to nucleosides with potent anti-HCV activity, and their analogues, and (iii) methods to prepare the anti-HCV nucleosides containing the 2′-deoxy-2′-fluoro-2′-C-methyl-ß-D-ribofuranosyl nucleosides from a preformed, preferably naturally-occurring, nucleoside.

Claims (15)

1. A compound of formula 51B:

wherein:

each R 1 is independently (C 1 -C 6 ) alkyl, phenyl or benzyl; or two R 1 with the carbon attached thereto form a cyclopentyl or cyclohexanyl group;

R 2 is hydrogen, (C 1 -C 6 ) alkyl, hydroxymethyl, methoxymethyl, halomethyl, vinyl, halovinyl, ethynyl, haloethynyl, allyl or haloallyl;

R 3 is (C 1 -C 6 ) alkyl, hydroxymethyl, methoxymethyl, halomethyl, vinyl, halovinyl, ethynyl, haloethynyl, allyl or haloallyl;

R 4 is hydrogen, aryl, arylalkyl or (C 1 -C 6 ) alkyl;

Nu is F, Cl, Br, N 3 , CN, NO 3 , CF 3 , SCN, OR or NR 2 where each R is independently arylalkyl or (C 1 -C 6 ) alkyl; and

M + is tetrabutylammonium, tetraethylammonium, tetramethylammonium, sodium, potassium, cesium, rubidium or silver.

2. A compound of formula 52B:

wherein:

each R 1 is independently (C 1 -C 6 ) alkyl, phenyl or benzyl; or two R 1 with the carbon attached thereto form a cyclopentyl or cyclohexanyl group;

R 2 is hydrogen, (C 1 -C 6 ) alkyl, hydroxymethyl, methoxymethyl, halomethyl, vinyl, halovinyl, ethynyl, haloethnyl, allyl or haloallyl;

R 3 is (C 1 -C 6 ) alkyl, hydroxymethyl, methoxymethyl, halomethyl, vinyl, halovinyl, ethynyl, haloethynyl, allyl or haloallyl;

R 4 is hydrogen, aryl, arylalkyl or (C 1 -C 6 ) alkyl; and

Nu is F, Cl, Br, N 3 , CN, NO 3 , CF 3 , SCN, OR or NR 2 where each R is independently arylalkyl or (C 1 -C 6 ) alkyl.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 20, 2022
From: GILEAD PHARMASSET LLC
To: GILEAD SCIENCES, INC.
Reel/Frame 058784/0567 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 26, 2017
From: CHUN, BYOUNG-KWON; WANG, PEIYUAN; DU, JINFA; RACHAKONDA, SUGUNA
To: PHARMASSET, INC.
Reel/Frame 042816/0854 →
CHANGE OF NAME Recorded Jun 26, 2017
From: PHARMASSET, INC.
To: GILEAD PHARMASSET LLC
Reel/Frame 042992/0459 →
Cited By (2)
US 12,458,656 US 12,686,697